|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|
| Cash flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest earned on marketable securities held in Trust Account | |
| Change in fair value of warrant liability | |
| Change in over-allotment option liability | |
| Warrant issuance costs | |
| Deferred tax provision | |
| Changes in current assets and current liabilities: | |
| Prepaid expenses | |
| Accounts payable and accrued expenses | |
| Income taxes payable | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Net cash used in investing activities | |
| Cash flows from Financing Activities: | |
| Proceeds from issuance of Founder Shares | |
| Proceeds from promissory note - related party | |
| Proceeds from the partial exercise of over-allotment option, net of underwriting discounts paid | |
| Proceeds from the sale of Private Placement Warrants | |
| Proceeds from reimbursement by underwriters of offering costs | |
| Receipt of overpayment from related party | |
| Payment of promissory note - related party | |
| Payment of deferred offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, beginning of the year | |
| Cash, end of the year | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Deferred offering costs in accrued offering costs and expenses | |
| Initial value of Class A common stock subject to possible redemption, including accretion of carrying value to redemption value of $20,960,700 | |
| Remeasurement for Class A common stock to redemption amount | |
| Payment of offering costs made by sponsor | |
| Deferred underwriting fee payable | |
| Deferred offering cost charged to Additional paid-in capital | |
| Proceeds allocated to warrant liability | |
| Class A common stock subject to possible redemption, accretion of carrying value to redemption value |
Loading...
